Betta Pharmaceuticals Co Ltd (300558) — Capital Reinvestment Ratio
Betta Pharmaceuticals Co Ltd (300558) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥224.45 Million) in capital expenditures (CN¥90.43 Million). Check tangible equity quality of Betta Pharmaceuticals Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Betta Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Betta Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see Betta Pharmaceuticals Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd from 2011 to 2025. See 300558 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥911.26 Million | CN¥616.68 Million | ▼ -25.5% |
| 2024 | 0.91x | CN¥911.17 Million | CN¥827.59 Million | ▼ -24.2% |
| 2023 | 1.20x | CN¥914.23 Million | CN¥1.10 Billion | ▼ -63.6% |
| 2022 | 3.29x | CN¥306.74 Million | CN¥1.01 Billion | ▲ +128.8% |
| 2021 | 1.44x | CN¥526.63 Million | CN¥758.38 Million | ▲ +35.6% |
| 2020 | 1.06x | CN¥646.02 Million | CN¥685.84 Million | ▼ -5.0% |
| 2019 | 1.12x | CN¥555.07 Million | CN¥620.42 Million | ▼ -47.9% |
| 2018 | 2.15x | CN¥286.40 Million | CN¥614.83 Million | ▲ +2.0% |
| 2017 | 2.11x | CN¥278.26 Million | CN¥585.78 Million | ▲ +191.0% |
| 2016 | 0.72x | CN¥407.05 Million | CN¥294.50 Million | ▲ +108.8% |
| 2015 | 0.35x | CN¥385.56 Million | CN¥133.60 Million | ▼ -43.3% |
| 2014 | 0.61x | CN¥277.55 Million | CN¥169.73 Million | ▲ +408.2% |
| 2013 | 0.12x | CN¥190.34 Million | CN¥22.90 Million | ▼ -54.0% |
| 2012 | 0.26x | CN¥149.29 Million | CN¥39.05 Million | ▼ -82.1% |
| 2011 | 1.46x | CN¥34.80 Million | CN¥50.81 Million | — |